Univest
Univest
  • Markets

Ajooni Biotech Share Price Target 2026 Analyst Forecast Bull and Bear Case

  • June 5, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Ajooni Biotech Share Price Target 2026

The Ajooni Biotech share price target 2026 is Rs 4.81, implying approximately 20 percent upside from the current market price of Rs 4.01 (NSE: AJOONI). Q4 FY26 results announced May 30, 2026 are the key near-term re-rating trigger, with Animal Nutrition and Feed Supplements tailwinds and RBI rate cuts supporting the path to Rs 4.81.

The Ajooni Biotech share price target 2026 is Rs 4.81, based on analyst estimates and the FY27 earnings recovery thesis. Q4 FY26 results announced May 30, 2026 are the immediate trigger for re-rating Ajooni Biotech (NSE: AJOONI). This article covers the complete Ajooni Biotech share price target analysis including sector tailwinds, key risks, and the bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Ajooni Biotech Company Overview
  • Why Is the Ajooni Biotech Share Price Target Set at Rs 4.81 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • Structural Sector Tailwinds in Animal Nutrition and Feed Supplements
    • RBI Rate Cut Cycle and Lower Cost of Capital
    • Union Budget 2026-27 Policy Support
    • Improving FII Flows Post the April 2026 Tariff Shock
  • Ajooni Biotech Share Price Targets: Short Term, 12 Month, and Long Term
    • Short Term Ajooni Biotech Share Price Target: 3 to 6 Months
    • 12-Month Ajooni Biotech Share Price Target 2026
    • Long Term Ajooni Biotech Share Price Target: FY27 to FY28
  • Bull Case and Bear Case for the Ajooni Biotech Share Price Target
    • Bull Case Ajooni Biotech Share Price Target: Rs 5.81
    • Bear Case Ajooni Biotech Share Price Target: Rs 3.21
  • Key Risks to the Ajooni Biotech Share Price Target 2026
    • US Tariff and Global Macro Risk
    • Valuation and Earnings Miss Risk
    • Competitive Pressure in Animal Nutrition and Feed Supplements
    • FII Selling Pressure and Liquidity Risk
  • How to Invest in Ajooni Biotech
  • FAQs on Ajooni Biotech Share Price Target 2026
    • What is the Ajooni Biotech share price target for 2026?
    • Is Ajooni Biotech a good buy at the current price of Rs 4.01?
    • What is the 52 week high and low of Ajooni Biotech?
    • What are the key risks to the Ajooni Biotech share price target 2026?
    • What are the main catalysts for the Ajooni Biotech share price target?
    • What is the Ajooni Biotech share price target for 2027?

Ajooni Biotech Company Overview

Ajooni Biotech (NSE: AJOONI) is a Ludhiana-based animal nutrition company manufacturing cattle feed supplements, mineral mixtures, and poultry feed additives. At CMP Rs 4.01 against a 52 week range of Rs 2.80 to Rs 8.80, the stock trades at a meaningful discount to its 52 week high. Market capitalisation stands at Rs 11 crore with a trailing PE of sector-average.

Parameter Value
NSE Ticker AJOONI
Sector Animal Nutrition and Feed Supplements
CMP (May 30, 2026) Rs 4.01
52 Week High Rs 8.80
52 Week Low Rs 2.80
Market Cap Rs 11 crore
Trailing PE sector-average
12-Month Analyst Target Rs 4.81
Bull Case Target Rs 5.81
Bear Case Target Rs 3.21

3 Stocks Building Serious Momentum Right Now

When Univest analysts identify high-conviction stock opportunities, investors pay attention.

Our research team has now shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.

  • Discover stocks investors are actively accumulating
  • High-conviction opportunities backed by research
  • Designed for the next phase of market growth

Unlock the latest Top Stock Picks now on Univest

See the Stocks →

Why Is the Ajooni Biotech Share Price Target Set at Rs 4.81 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Ajooni Biotech share price target 2026 of Rs 4.81 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the recovery trajectory are the most direct catalyst for re-rating from CMP Rs 4.01 toward the Ajooni Biotech share price target of Rs 4.81.

Structural Sector Tailwinds in Animal Nutrition and Feed Supplements

The Animal Nutrition and Feed Supplements sector is expanding on the back of India’s strong domestic demand, PLI scheme support, and rising corporate investment. Ajooni Biotech’s market position creates a structural growth runway supporting the Ajooni Biotech share price target consensus of Rs 4.81 and the bull case of Rs 5.81.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, which began in early 2026, reduces Ajooni Biotech’s borrowing costs and stimulates demand across end markets. Lower interest costs improve EPS trajectory, directly supporting the Ajooni Biotech share price target 2026 of Rs 4.81.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Ajooni Biotech’s Animal Nutrition and Feed Supplements operations, improving the probability of achieving the Ajooni Biotech share price target of Rs 4.81.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering through FY27. At sector-average PE, Ajooni Biotech is positioned as a beneficiary of institutional reallocation supporting the path to Rs 4.81.

Ajooni Biotech Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Ajooni Biotech Share Price Target: 3 to 6 Months

The near-term Ajooni Biotech share price target is anchored to support near the 52 week low of Rs 2.80. A confirmed Q4 FY26 earnings recovery and positive FY27 guidance are the triggers for an initial 10 to 15 percent re-rating toward Rs 4.81.

12-Month Ajooni Biotech Share Price Target 2026

The 12-month Ajooni Biotech share price target 2026 is Rs 4.81, implying approximately 20 percent upside from CMP Rs 4.01. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker AJOONI.

Long Term Ajooni Biotech Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Ajooni Biotech share price target is Rs 5.81 in the bull case, assuming full earnings delivery through FY27 to FY28 and sector re-rating in the Animal Nutrition and Feed Supplements space.

Bull Case and Bear Case for the Ajooni Biotech Share Price Target

Bull Case Ajooni Biotech Share Price Target: Rs 5.81

The bull case for the Ajooni Biotech share price target of Rs 5.81 materialises when FY27 earnings beat analyst estimates, sector tailwinds accelerate, and FII flows return strongly to Indian equities. The stock re-rates toward higher peer multiples, making Rs 5.81 achievable within FY28.

Bear Case Ajooni Biotech Share Price Target: Rs 3.21

The bear case sees the Ajooni Biotech share price target testing Rs 3.21 if FY27 earnings disappoint and FII outflows persist. At Rs 3.21, the stock approaches the 52 week low support of Rs 2.80, requiring a full reassessment of the investment thesis.

Scenario Target Key Conditions
Bull Case Rs 5.81 FY27 earnings beat, sector re-rating, strong FII inflows
Base Case Rs 4.81 In-line FY27 delivery, partial FII recovery
Bear Case Rs 3.21 FY27 earnings miss, guidance cut, sustained FII outflows

Key Risks to the Ajooni Biotech Share Price Target 2026

US Tariff and Global Macro Risk

The 26 percent US reciprocal tariff announced April 2, 2026 triggered FII outflows across Indian equities. Prolonged trade tension or a global demand slowdown remains the most prominent macro risk to the Ajooni Biotech share price target 2026 of Rs 4.81.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could trigger multiple compression, posing a direct risk to the Ajooni Biotech share price target of Rs 4.81. Monitoring quarterly results closely is essential for investors in Ajooni Biotech.

Competitive Pressure in Animal Nutrition and Feed Supplements

Intensifying competition in the Animal Nutrition and Feed Supplements sector could compress Ajooni Biotech’s pricing power and market share over the medium term, which must be factored into any assessment of the Ajooni Biotech share price target of Rs 4.81.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows from Indian equities can delay re-rating toward the Ajooni Biotech share price target of Rs 4.81 regardless of company-level operational improvement through FY27.

How to Invest in Ajooni Biotech

Check the Univest Screener for live data

Begin by reviewing Ajooni Biotech’s Q4 FY26 results, annual report, and FY27 guidance statements before forming a view on the Ajooni Biotech share price target of Rs 4.81. Focus on revenue growth trajectory, margin trends, and management commentary on sector headwinds and opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Ajooni Biotech (NSE: AJOONI) with full regulatory protection. Ensure KYC is complete and understand the Animal Nutrition and Feed Supplements sector dynamics before executing any position.

Plan your entry near the 52 week low support of Rs 2.80. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the Ajooni Biotech share price target of Rs 4.81. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in smaller-cap Animal Nutrition and Feed Supplements companies where liquidity and volatility can amplify losses.

Always consult a SEBI registered financial advisor before investing based on any Ajooni Biotech share price target estimate. A registered advisor personalises recommendations based on your risk profile and financial goals. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Ajooni Biotech’s live price and get daily stock recommendations.

Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.

FAQs on Ajooni Biotech Share Price Target 2026

What is the Ajooni Biotech share price target for 2026?

Ans. The Ajooni Biotech share price target 2026 is Rs 4.81, implying approximately 20 percent upside from CMP Rs 4.01. The bull case target is Rs 5.81 and the bear case target is Rs 3.21.

Is Ajooni Biotech a good buy at the current price of Rs 4.01?

Ans. At Rs 4.01, Ajooni Biotech offers potential upside to the share price target of Rs 4.81 if FY27 earnings recover as projected. Consult a SEBI registered financial advisor before making any investment decision.

What is the 52 week high and low of Ajooni Biotech?

Ans. The 52 week high of Ajooni Biotech is Rs 8.80 and the 52 week low is Rs 2.80. At CMP Rs 4.01, the stock offers upside potential toward the 12-month share price target of Rs 4.81.

What are the key risks to the Ajooni Biotech share price target 2026?

Ans. Key risks to the Ajooni Biotech share price target of Rs 4.81 include an FY27 earnings miss, US tariff-driven FII outflows, competitive pressure in Animal Nutrition and Feed Supplements, and broader market volatility.

What are the main catalysts for the Ajooni Biotech share price target?

Ans. Primary catalysts include FY27 PAT recovery, structural tailwinds in Animal Nutrition and Feed Supplements, RBI rate cut support, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities through FY27.

What is the Ajooni Biotech share price target for 2027?

Ans. The long-term Ajooni Biotech share price target for FY27 to FY28 is Rs 5.81 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply